Product Images Nevirapine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Nevirapine NDC 33342-238 by Macleods Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

nevirapine er 100s carton

nevirapine er 100s carton

This is a product description for Nevirapine Extended-Release Tablets, USP manufactured by Macleods Pharma. The package contains 100 tablets, each tablet containing 400 mg Nevirapine. The tablets must be swallowed whole and should not be chewed, crushed, or divided. Dosage information must be obtained from the package insert. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F) with excursions allowed to 15° to 30°C (59° to 86°F). The package is not child-resistant. The text also includes batch numbers, manufacturing locations, and other company-specific information.*

nevirapine er 30s bottle

nevirapine er 30s bottle

This is a medication called Nevirapine, USP. It comes in the form of extended-release tablets that must be swallowed whole and not chewed, crushed or divided. The usual dosage information can be found in the package insert. They should be stored at a controlled room temperature of 20°C to 25°C (68° to 77°F) and should be preserved in well-closed containers. The medication guide accompanies each patient. This drug is manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. in Princeton, NJ.*

formula - nevirapine formula

formula - nevirapine formula

str - nevirapine str

str - nevirapine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.